Active Biotech AB publ announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was SEK 0.9 million compared to SEK 4.7 million a year ago. Operating loss was SEK 9.3 million compared to SEK 6.9 million a year ago. Net loss was SEK 9.3 million compared to SEK 8.7 million a year ago. Basic loss per share was SEK 0.06 compared to SEK 0.06 a year ago. For the nine months, sales was SEK 7.5 million compared to SEK 15.2 million a year ago. Operating loss was SEK 21.1 million compared to SEK 22.8 million a year ago. Net loss was SEK 22.9 million compared to SEK 28 million a year ago. Basic loss per share was SEK 0.16 compared to SEK 0.21 a year ago.